Pau Montesinos, MD
Hospital Universitario La Fe · Trial Coordinator, Institution Contact
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pau Montesinos, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:41 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04687761 · Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years OldPETHEMA Foundation · completed · Leukemia, Myeloid, Acute, De Novo, Age More 60yr · principal investigator
- Ph1/Ph2NCT04112589 · A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First TreatmentPETHEMA Foundation · unknown · Acute Myeloid Leukemia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.